Ask about this productRelated genes to: SLC25A13 antibody
- Gene:
- SLC25A13 NIH gene
- Name:
- solute carrier family 25 member 13
- Previous symbol:
- CTLN2
- Synonyms:
- CITRIN, ARALAR2
- Chromosome:
- 7q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1999-07-13
- Date modifiied:
- 2016-02-18
Related products to: SLC25A13 antibody
Related articles to: SLC25A13 antibody
- Citrin deficiency (CD) is an autosomal recessive disease caused by mutations in the SLC25A13 gene. This study aimed to expand the current body of data on Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) by analyzing their clinical characteristics, genetic mutation spectrum, and long-term follow-up outcomes. - Source: PubMed
Publication date: 2026/05/08
Chen LingliLou JinganLuo YouyouFang YouhongSun MingfangYu Jindan - To retrospectively investigate the clinical characteristics and etiological spectrum of infantile cholestasis, with an emphasis on evolving diagnostic approaches. - Source: PubMed
Publication date: 2026/04/22
Tang Yun-PingWei Xu-XiaXue NingYang Hai-YingLi Hua - Although primarily reported in solid organ transplant recipients and patients undergoing chimeric antigen receptor T-cell immunotherapy (CAR-T), non-hepatic hyperammonemia (NHHA) is a rare but lethal complication in the broader context of post- chemo-immunotherapy hematologic malignancies. It often presents with unexplained encephalopathy that mimics primary central nervous system (CNS) progression, leading to diagnostic delays. With the expanding use of bispecific antibodies (e.g., glofitamab), the etiology of NHHA, particularly the complex interplay between opportunistic infections and potential metabolic susceptibility, remains poorly understood. - Source: PubMed
Wu YinshanGuo XiuliuWang XiaolingGuo Feng - Oxidative stress (OS) plays a role in hypertension development, but the underlying genetic mechanisms are not completely understood. This study aimed to investigate the association between OS-related genes and hypertension by performing an integrative multi-omics analysis using summary-data-based Mendelian randomization (SMR) and colocalization approaches. - Source: PubMed
Publication date: 2026/03/25
Zhang YueMeng JinyangYan YuchengTang HongZhong DonglingLi YuxiXue PeiwenZhang AnrenJin RongjiangLi Juan - The optimal disease spectrum for carrier screening (CS) remains debated. We aimed to characterise the carrier landscape and quantify the at-risk couple rate (ACR) components in a Chinese population to guide panel design. - Source: PubMed
Publication date: 2026/04/03
Liu ShaCao LiyuanZhang Victor WeiHuang ShuangLiu HaipengWei XiangLuo YuanLi YueZhou LinJiang LinzhiZhu QianLiu Hongqian